European Leukemia Trial Registry
Trial: Gravitas-301 (MEDPACE)

More Details
Scientific Title A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft Versus-Host Disease
Short Title Gravitas-301 (MEDPACE)
Trialgroup NN
Type of Trial multicentric, randomized, placebo-kontrolliert, double-blind, double-group
Disease Acute lymphoblastic leukemia(ALL) Stem cell transplantation
Age >= 18 years
Status Active
Start of Recruitment 01.02.2018
Shortprotocol Shortprotocol
created 27.01.2020 Student Studienregister
changed 27.01.2020 Student Studienregister
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org